Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 525-530

  Ward, Laura S ^a   Brenta, Gabriela ^a   Medvedovic, Mario ^a   Fagin, James A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ARTICLE; CHROMOSOME; CLINICAL TRIAL; CONTROLLED STUDY; GENETIC STABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; META ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECTROPHOTOMETRY; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, FOLLICULAR; ALLELES; CARCINOMA, PAPILLARY; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 3; GENE DELETION; HUMANS; LOSS OF HETEROZYGOSITY; THYROID NEOPLASMS;

EID: 0031791046     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.2.525     Document Type: Article

References (28)

1. Namba H, Matsuo K, Fagin JA. 1990 Clonal composition of benign and malignant human thyroid tumors. J Clin Invest. 86:120-125.
2. Sherr CJ. 1996 Cancer cell cycles. Science. 274:1672-1677.
3. Stark GR. 1993 Regulation and mechanisms of mammalian gene amplification. Adv Cancer Res. 61:87-113.
4. Fearon ER, Vogelstein B. 1990 A genetic model for colorectal tumorigenesis. Cell. 61:759-767.
5. Bates AS, Farrell WE, Bicknell EJ, et al. 1997 Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as prognostic marker. J Clin Endocrinol Metab. 82:818-824.
6. Herrmann MA, Hay ID, Bartelt DH, et al. 1991 Cytogenetic and molecular genetic studies of follicular and papillary thyroid tumors. J Clin Invest. 88:1596-1604.
7. Matsuo K, Tang S-H, Fagin JA. 1991 Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms. Mol Endocrinol. 5:1873-1879.
8. Kubo K, Yoshimoto K, Yokogoshi Y, Tsuyuguchi M, Saito S. 1991 Loss of heterozygosity on chromosome 1p in thyroid adenoma and medullary carcinoma, but not in papillary carcinoma. Jpn J Cancer Res. 82:1097-1103.
9. Zedenius J, Wallin G, Svensson A, et al. 1995 Allelotyping of follicular thyroid tumors. Hum Genet. 96:27-32.
10. Zedenius J, Wallin G, Svensson A, et al. 1996 Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Hum Genet. 97:299-303.
11. Grebe SKG, Hay ID, Jenkins RB, Wu S-C, Maciel L, Eberhardt NL. 1996 Frequent loss of heterozygosity on the distal portions of chromosomes 3p and 17p in follicular thyroid carcinoma is rarely associated with mutations in the known tumor suppressor genes VHL and p53 [Abstract]. Thyroid. 137:S70-S79.
12. Tung WS, Shevlin DW, Kaleem Z, Tribune DJ, Wells SA, Goodfellow PJ. 1997 Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss. Genes Chromosomes Cancer. 19:43-51.
13. Marsh DJ, Zheng Z, Zedenius J, et al. 1997 Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas. Cancer Res. 57:500-503.
14. Califano JA, Johns III MM, Westra WH, et al. 1996 An allelotype of papillary thyroid cancer. Int J Cancer. 69:442-444.
15. Davis LG, Dibner MD, Battey JF. Basic methods in molecular biology. New York: Elsevier; 133-135.
16. Li L, Li X, Francke U, Cohen SN. 1997 The TSG 101 tumor susceptibility gene is located on chromosome 11p15 and is mutated in human breast cancer. Cell. 88:143-154.
17. Korenberg JR, Chen XN, Gonsky R, Brenta G, Fagin JA. Examination of thyroid tumor DNA by comparative genomic hybridization reveals multiple loci of gene amplification. Proc of the 76th Annual Meet of The Endocrine Society. 1994; 1345.
18. James CD, Carlbom E, Dumanski JP, et al. 1988 Clonal genomic alterations in glioma malignancy stages. Cancer Res. 48:5546-5551.
19. Adams WT, Skopek RT. 1987 Statistical test for the comparison of samples from mutational spectra. J Mol Biol. 194:391-396.
20. Westphal PH, Young SS. 1992 Resampling-based multiple testing. New York: Wiley Interscience; 44-45.
21. Jenkins RB, Hay ID, Herath JF, et al. 1990 Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer. 66:1213-1220.
22. Roque L, Clode AL, Gomes P, Rosa-Santos J, Soares J, Castedo S. 1995 Cytogenetic findings in 31 papillary thyroid carcinomas. Genes Chromosomes Cancer. 13:157-162.
23. Belge G, Thode B, Rippe V, Bartnizke S, Bullerdiek J. 1994 A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors. Hum Genet. 94:198-202.
24. Taruscio D, Carcangiu ML, Ried T, Ward DC. 1994 Numerical chromosomal aberrations in thyroid tumors detected by double fluorescence in situ hybridization. Genes Chromosomes Cancer. 9:180-185.
25. Antonini P, Levy N, Caillou B, et al. 1993 Numerical aberrations, including trisomy 22 as the sole anomaly, are recurrent in follicular thyroid adenomas. Genes Chromosomes Cancer. 8:63-66.
26. Bondeson L, Bengtsson A, Bondeson AG, et al. 1989 Chromosome studies in thyroid neoplasia. Cancer. 64:680-685.
27. van den Berg E, van Doormaal JJ, Oosterhuis JV, et al. 1991 Chromosomal aberrations in follicular thyroid carcinoma. Cancer Genet Cytogenet. 54:215-222.
28. Chandrashekharappa SC, Guru SC, Manickam P, et al. 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 276:404-407.